Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms

Blood (2021) 137 (14): 1905–1919.

https://doi.org/10.1182/blood.2020009088

Published: 2021

Includes: Supplemental data

Journal Articles

Single-Cell RNA-Seq Reveals AML Cellular Hierarchies Relevant to Clinical Outcomes and Immunity

Peter Van Galen, PhD, Volker Hovestadt, PhD, Marc Wadsworth II, Travis Hughes, Gabriel Kenneth Griffin, MD, Julia A. Verga, Jason Stephansky, Timothy J. Pastika, Jennifer Lombardi Story, Geraldine S. Pinkus, MD, Olga Pozdnyakova, MD PhD, Ilene Galinsky, Richard M. Stone, MD, Timothy A. Graubert, MD, Alex K. Shalek, PhD, Jon C. Aster, MD PhD, Andrew A. Lane, MD PhD, Bradley E. Bernstein, MD PhD

Blood (2018) 132 (Supplement 1): 542.

https://doi.org/10.1182/blood-2018-99-113502

Published: 2018

Journal Articles

Assessment of CD52 Expression in "Double-Hit" and "Double-Expressor" Lymphomas: Implications for Clinical Trial Eligibility

Jeffrey W. Craig, MD PhD, Michael J. Mina, MD PhD, Jennifer Crombie, MD, Ann S LaCasce, MD MSc, David M. Weinstock, MD, Geraldine S. Pinkus, Olga Pozdnyakova, MD PhD

Blood (2017) 130 (Supplement 1): 4035.

https://doi.org/10.1182/blood.V130.Suppl_1.4035.4035

Published: 2017

Journal Articles

Systematic KIT Sequencing Identifies Unsuspected Systemic Mastocytosis with Associated Hematological Neoplasm

Elizabeth A Morgan, MD, Jeffrey W. Craig, MD PhD, Annette S. Kim, MDPhD, Geraldine S. Pinkus, Jon C. Aster, MD PhD, Frank C Kuo, MBBS, PhD, David P. Steensma, MD, R. Coleman Lindsley, MD PhD, Daniel J. DeAngelo, MD

Blood (2017) 130 (Supplement 1): 2923.

https://doi.org/10.1182/blood.V130.Suppl_1.2923.2923

Published: 2017

Journal Articles

Modeling Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia in Transgenic Mice Using Human MYD88 L256P Mutated Protein

Tomasz Sewastianik, MSc,PhD, Maria Luisa Guerrera, MD, Meng Jiang, MD, Peter S. Dennis, Jianjun Zhao, MD, Guang Yang, PhD, Zachary Hunter, PhD, Geraldine S. Pinkus, Petr Jarolim, MD PhD, Wong Kwok-Kin, MD PhD, Steven P Treon, MDPhDFRCP, Ruben D. Carrasco, MD PhD

Blood (2017) 130 (Supplement 1): 2510.

https://doi.org/10.1182/blood.V130.Suppl_1.2510.2510

Published: 2017

Journal Articles

Expression of Major Histocompatibility Complex (MHC) Class II, but Not MHC Class I, Predicts Outcome in Patients with Classical Hodgkin Lymphoma (cHL) Treated with Nivolumab (Programmed Death-1 [PD-1] Blockade)

Blood (2017) 130 (Supplement 1): 1450.

https://doi.org/10.1182/blood.V130.Suppl_1.1450.1450

Published: 2017

Journal Articles

Constitutive Activation of Ras and Inactivation of Ink4a/Arf Allele Induce a Fully Penetrant B-Cell Acute Lymphoblastic Leukemia Phenotype in Mice

Tomasz Sewastianik, MSc,PhD, Meng Jiang, MD, Kumar Sukhdeo, MD PhD, Sanjay Patel, MD MPH, MSc, Yue Kang, Ahmad Alduaij, MD, Peter S. Dennis, Jessie Xiong, Geraldine S. Pinkus, Jeremy N. Rich, MD, Madeleine E. Lemieux, PhD, Norman E. Sharpless, MD, Ruben D. Carrasco, MD PhD

Blood (2017) 130 (Supplement 1): 1222.

https://doi.org/10.1182/blood.V130.Suppl_1.1222.1222

Published: 2017

Journal Articles

Germinal Center-Derived Lymphomas and Plasmacytomas in Mice with Targeted Deletion of MiR-15a/16-1 in Activated B Cells

Tomasz Sewastianik, PhD, Jianjun Zhao, MD PhD, Meng Jiang, MD, Jianli Wang, MD PhD, Vinodh Pillai, MD PhD, Peter S. Dennis, BS, Jianhong Lin, MD M.Sc, Daniel Brooks, Mary Bouxsein, PhD, Geraldine S Pinkus, MD, Petr Jarolim, MD PhD, Davide Robbiani, Irene M. Ghobrial, MD, Kenneth C. Anderson, MD, Ruben D. Carrasco, MD PhD

Blood (2016) 128 (22): 743.

https://doi.org/10.1182/blood.V128.22.743.743

Published: 2016

Journal Articles

T-Cell Lymphoma Patient-Derived Xenografts and Newly Developed Cell Lines Recapitulate Aspects of Disease Biology and Represent Novel Tools for Preclinical Drug Development

Blood (2016) 128 (22): 3015.

https://doi.org/10.1182/blood.V128.22.3015.3015

Published: 2016

Journal Articles

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease

Blood (2016) 127 (18): 2203–2213.

https://doi.org/10.1182/blood-2015-09-672352

Published: 2016

Includes: Supplemental data

Journal Articles

Targetable genetic features of primary testicular and primary central nervous system lymphomas

Blood (2016) 127 (7): 869–881.

https://doi.org/10.1182/blood-2015-10-673236

Published: 2016

Includes: Supplemental data

Journal Articles

Diffuse Large B-Cell Lymphoma Patient-Derived Xenograft Models Capture Molecular and Biologic Heterogeneity and Inform Therapy

Blood (2015) 126 (23): 817.

https://doi.org/10.1182/blood.V126.23.817.817

Published: 2015

Journal Articles

B and T-Cell Lymphoma Patient-Derived Xenografts Recapitulate Aspects of Disease Biology and Progression and Represent Novel Tools for Preclinical Drug Development

Blood (2015) 126 (23): 4001.

https://doi.org/10.1182/blood.V126.23.4001.4001

Published: 2015

Journal Articles

Phenotypic and Transcriptional Characterization of Non-Hodgkin Lymphomas from Malawi Defines Targetable Disease Subsets

Elizabeth A. Morgan, MD, M. Patrick Sweeney, Tamiwe Tomoka, MD, Nadja Kopp, M.S., Robert A Redd, MS, Christopher Daniel Carey, MD,, Leo Masamba, MD, Steve Kamiza, MD, Geraldine S Pinkus, MD, Donna S. Neuberg, Sc.D., Scott J. Rodig, MD, PhD, Danny A. Milner, Jr., MD, M.Sc., David M. Weinstock, MD

Blood (2015) 126 (23): 2655.

https://doi.org/10.1182/blood.V126.23.2655.2655

Published: 2015

Journal Articles

Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement

Abner Louissaint, Jr, Adam M. Ackerman, Dora Dias-Santagata, Judith A. Ferry, Ephraim P. Hochberg, Mary S. Huang, A. John Iafrate, Daniel O. Lara, Geraldine S. Pinkus, Itziar Salaverria, Zakir Siddiquee, Reiner Siebert, Howard J. Weinstein, Lawrence R. Zukerberg, Nancy Lee Harris, Robert P. Hasserjian

Blood (2012) 120 (12): 2395–2404.

https://doi.org/10.1182/blood-2012-05-429514

Published: 2012

Includes: Supplemental data

Journal Articles

A Somatic Variant in MYD88 (L265P) Revealed by Whole Genome Sequencing Differentiates Lymphoplasmacytic Lymphoma From Marginal Zone Lymphomas

Lian Xu, Aliyah R. Sohani, MD, Luca Arcaini, MD, Zachary Hunter, Guang Yang, PhD, Yangsheng Zhou, MD, Xia Liu, MD, Yang Cao, MD, Robert Manning, Christopher J Patterson, Leukothea Ioakimidis, Christina Tripsas, Geraldine S. Pinkus, MD, Nancy Lee Harris, MD, Scott J. Rodig, MD, PhD, Steven Treon, MD, PhD

Blood (2011) 118 (21): 261.

https://doi.org/10.1182/blood.V118.21.261.261

Published: 2011

Journal Articles

Evaluation of CD52 Expression in Hematopoietic Neoplasms by Standard Immunohistochemistry: Implications for the Expanded Use of Alemtuzumab (CAMPATH-1H) in the Treatment of Hematological Malignancies.

Scott J. Rodig, MD, PhD, Jeremy S. Abramson, MD, Geraldine S. Pinkus, MD, Steven P. Treon, MD, PhD, Margaret A. Shipp, MD, Jeffery L. Kutok, MD, PhD

Blood (2005) 106 (11): 3346.

https://doi.org/10.1182/blood.V106.11.3346.3346

Published: 2005

Journal Articles

NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

Friedrich Feuerhake, Jeffery L. Kutok, Stefano Monti, Wen Chen, Ann S. LaCasce, Giorgio Cattoretti, Paul Kurtin, Geraldine S. Pinkus, Laurence de Leval, Nancy L. Harris, Kerry J. Savage, Donna Neuberg, Thomas M. Habermann, Riccardo Dalla-Favera, Todd R. Golub, Jon C. Aster, Margaret A. Shipp

Blood (2005) 106 (4): 1392–1399.

https://doi.org/10.1182/blood-2004-12-4901

Published: 2005

Includes: Supplemental data

Journal Articles

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

Blood (2005) 105 (5): 1851–1861.

https://doi.org/10.1182/blood-2004-07-2947

Published: 2005

Includes: Supplemental data

Journal Articles

Molecular Profiling of Diffuse Large B-Cell Lymphoma Identifies Robust Subtypes Including One Characterized by Host Inflammatory Response.

Blood (2004) 104 (11): 25.

https://doi.org/10.1182/blood.V104.11.25.25

Published: 2004

NARROW

miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms

Single-Cell RNA-Seq Reveals AML Cellular Hierarchies Relevant to Clinical Outcomes and Immunity

Assessment of CD52 Expression in "Double-Hit" and "Double-Expressor" Lymphomas: Implications for Clinical Trial Eligibility

Systematic KIT Sequencing Identifies Unsuspected Systemic Mastocytosis with Associated Hematological Neoplasm

Modeling Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia in Transgenic Mice Using Human MYD88 L256P Mutated Protein

Expression of Major Histocompatibility Complex (MHC) Class II, but Not MHC Class I, Predicts Outcome in Patients with Classical Hodgkin Lymphoma (cHL) Treated with Nivolumab (Programmed Death-1 [PD-1] Blockade)

Constitutive Activation of Ras and Inactivation of Ink4a/Arf Allele Induce a Fully Penetrant B-Cell Acute Lymphoblastic Leukemia Phenotype in Mice

Germinal Center-Derived Lymphomas and Plasmacytomas in Mice with Targeted Deletion of MiR-15a/16-1 in Activated B Cells

T-Cell Lymphoma Patient-Derived Xenografts and Newly Developed Cell Lines Recapitulate Aspects of Disease Biology and Represent Novel Tools for Preclinical Drug Development

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease

Targetable genetic features of primary testicular and primary central nervous system lymphomas

Diffuse Large B-Cell Lymphoma Patient-Derived Xenograft Models Capture Molecular and Biologic Heterogeneity and Inform Therapy

B and T-Cell Lymphoma Patient-Derived Xenografts Recapitulate Aspects of Disease Biology and Progression and Represent Novel Tools for Preclinical Drug Development

Phenotypic and Transcriptional Characterization of Non-Hodgkin Lymphomas from Malawi Defines Targetable Disease Subsets

Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement

A Somatic Variant in MYD88 (L265P) Revealed by Whole Genome Sequencing Differentiates Lymphoplasmacytic Lymphoma From Marginal Zone Lymphomas

Evaluation of CD52 Expression in Hematopoietic Neoplasms by Standard Immunohistochemistry: Implications for the Expanded Use of Alemtuzumab (CAMPATH-1H) in the Treatment of Hematological Malignancies.

NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

Molecular Profiling of Diffuse Large B-Cell Lymphoma Identifies Robust Subtypes Including One Characterized by Host Inflammatory Response.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only